MPG.eBooks - Search Results

41

CADTH Canadian Drug Expert Committee recommendation: Ulipristal acetate (Fibristal -- Allergan Inc.) : indication: uterine fibroids

Published 2017

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Leiomyoma / drug therapy...”

Read Now

42

Clinical review report: Upadacitinib (Rinvoq) (AbbVie) : indication : for the treatment of adults with moderately to severely active rheumatoid arthritis who have had an inadequate...

Published 2020

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Arthritis, Rheumatoid / drug therapy...”

Read Now

43

CADTH Canadian Drug Expert Committee recommendation: Ulipristal acetate (Fibristal -- Allergan Inc.) : indication: uterine fibroids

Published 2017

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Leiomyoma / drug therapy...”

Read Now

44

CADTH Canadian Drug Expert Committee recommendation: Baricitinib (Olumiant -- Eli Lilly Canada Inc.) : indication : for use in combination with methotrexate (MTX) for the treatment...

Published 2019

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Arthritis, Rheumatoid / drug therapy...”

Read Now

45

CADTH Canadian drug expert committee recommendation: Vortioxetine (Trintellix --Lundbeck Canada Inc.) : indication: for the treatment of major depressive disorder in adults

Published 2020

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Depressive Disorder, Major / drug therapy...”

Read Now

46

CADTH Canadian Drug Expert Committee recommendation: Iron isomaltoside 1000 (Monoferric -- pharmacosmos A/S) : indication: for the treatment of iron deficiency anemia in adult pati...

Published 2020

CADTH

“... of or unresponsiveness to oral iron therapy only if the following conditions are met: Conditions for Reimbursement...”

Read Now

47

CADTH Canadian Drug Expert Committee recommendation: Iron isomaltoside 1000 (Monoferric -- pharmacosmos A/S) : indication: for the treatment of iron deficiency anemia in adult pati...

Published 2020

CADTH

Subjects: “...Anemia, Iron-Deficiency / drug therapy...”

Read Now

48

CADTH Canadian Drug Expert Committee final recommendation: Tesamorelin (Egrifta -- Theratechnologies Inc.) indication : HIV-associated lipohypertherapy

Published 2016

Canadian Agency for Drugs and Technologies in Health

Subjects: “...HIV-Associated Lipodystrophy Syndrome / drug therapy...”

Read Now

49

CADTH Canadian Drug Expert Review Committee final recommendation: Riociguat (Adempas - Bayer HealthCare Inc.) : indication: pulmonary arterial hypertension

Published 2015

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Hypertension, Pulmonary / drug therapy...”

Read Now

50

CADTH Canadian Drug Expert Committee recommendation: Dupilumab (Dupixent -- Sanofi-Aventis Canada Inc.) : indication: atopic dermatitis

Published 2018

CADTH

Subjects: “...Dermatitis, Atopic / drug therapy...”

Read Now

51

CADTH Canadian Drug Expert Committee recommendation: Sodium zirconium cyclosilicate (Lokelma -- Astrazeneca Canada Inc.) : indication: hyperkalemia

Published 2020

CADTH

Subjects: “...Hyperkalemia / drug therapy...”

Read Now

52

Clinical review report: Lanadelumab (Takhzyro) (Shire pharma Canada ULC) : indication : for routine prevention of attacks of hereditary angioedema in adolescents and adults

Published 2020

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Angioedemas, Hereditary / drug therapy...”

Read Now

53

CADTH Canadian Drug Expert Committee recommendation: Brolucizumab (Beovu -- Novartis Pharmaceuticals Canada Inc.) : indication : treatment of neovascular (wet) age-related macular...

Published 2020

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Wet Macular Degeneration / drug therapy...”

Read Now

54

CADTH Canadian Drug Expert Committee recommendation: Tofacinitib (Xeljanz) : indication: for the treatment of adult patients with moderately to severely active ulcerative colitis (...

Published 2019

Canadian Agency for Drugs and Technologies in Health

Read Now

55

CADTH Canadian Drug Expert Committee recommendation: Obeticholic acid (Ocaliva--Intercept Pharmaceuticals Canada) : indication : primary biliary cholangitis

Published 2017

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Liver Cirrhosis, Biliary / drug therapy...”

Read Now

56

CADTH Canadian drug expert committee recommendation: Lanadelumab (Takhzyro -- shire pharma Canada ULC) : indication: for the routine prevention of attacks of hereditary angioedema...

Published 2019

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Angioedemas, Hereditary / drug therapy...”

Read Now

57

CADTH Canadian Drug Expert Committee recommendation: Fluticasone Propionate (Aermony respiclick -- Teva Canada Innovation) : indication : maintenance treatment of asthma in patient...

Published 2018

CADTH

Subjects: “...Asthma / drug therapy...”

Read Now

58

CADTH Canadian Drug Expert Committee recommendation: Fluticasone Propionate (Aermony respiclick -- Teva Canada Innovation) : indication : maintenance treatment of asthma in patient...

Published 2018

CADTH

Subjects: “...Asthma / drug therapy...”

Read Now

59

CADTH Canadian Drug Expert Committee recommendation: Nusinersen (Spinraza -- Biogen Canada Inc.) : indication : treatment of 5q spinal muscular atrophy

Published 2017

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Muscular Atrophy, Spinal / drug therapy...”

Read Now

60

CADTH Canadian Drug Expert Committee recommendation: Cysteamine delayed-release (Procysbi -- Horizon Pharma Ireland Ltd.) : indication : nephropathic cystinosis

Published 2018

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Cystinosis / drug therapy...”

Narrow Search